Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rahmer Peter | See remarks | Sep 27 '24 | Sale | 7.51 | 245 | 1,840 | 391,684 | Oct 01 04:07 PM | Catinazzo Thomas | Chief Financial Officer | Sep 27 '24 | Sale | 7.46 | 6,457 | 48,184 | 313,193 | Oct 01 04:07 PM | Bergstrom Donald A | President, R&D | Sep 27 '24 | Sale | 7.51 | 648 | 4,866 | 523,433 | Oct 01 04:07 PM | Adams Brian | Chief Legal Officer | Sep 27 '24 | Sale | 7.51 | 295 | 2,215 | 323,539 | Oct 01 04:06 PM | THOMAS J CATINAZZO | Officer | Sep 27 '24 | Proposed Sale | 7.46 | 6,162 | 45,977 | | Sep 27 04:27 PM | Catinazzo Thomas | Chief Financial Officer | Jul 29 '24 | Sale | 8.56 | 10,780 | 92,316 | 319,650 | Jul 31 06:43 PM | Rahmer Peter | See remarks | Jul 30 '24 | Sale | 8.28 | 15,128 | 125,260 | 405,637 | Jul 31 06:43 PM | Rahmer Peter | See remarks | Jul 29 '24 | Sale | 8.54 | 13,523 | 115,543 | 420,765 | Jul 31 06:43 PM | Rahmer Peter | See remarks | Jul 31 '24 | Sale | 8.19 | 13,708 | 112,269 | 391,929 | Jul 31 06:43 PM | Bergstrom Donald A | President, R&D | Jul 29 '24 | Sale | 8.85 | 2,698 | 23,877 | 524,081 | Jul 31 06:42 PM | Adams Brian | Chief Legal Officer | Jul 29 '24 | Sale | 8.85 | 1,638 | 14,496 | 323,834 | Jul 31 06:42 PM | PETER J RAHMER | Officer | Jul 31 '24 | Proposed Sale | 8.19 | 13,708 | 112,245 | | Jul 31 04:06 PM | PETER J RAHMER | Officer | Jul 30 '24 | Proposed Sale | 8.28 | 15,128 | 125,290 | | Jul 30 04:19 PM | Patel Sanjiv | President and CEO | Jul 25 '24 | Option Exercise | 5.04 | 50,000 | 252,000 | 816,130 | Jul 29 06:37 PM | Patel Sanjiv | President and CEO | Jul 26 '24 | Option Exercise | 5.04 | 36,706 | 184,998 | 802,836 | Jul 29 06:37 PM | Patel Sanjiv | President and CEO | Jul 25 '24 | Sale | 9.16 | 50,000 | 458,000 | 766,130 | Jul 29 06:37 PM | Patel Sanjiv | President and CEO | Jul 26 '24 | Sale | 9.07 | 36,706 | 332,923 | 766,130 | Jul 29 06:37 PM | THOMAS J CATINAZZO | Officer | Jul 29 '24 | Proposed Sale | 8.51 | 9,078 | 77,243 | | Jul 29 04:29 PM | PETER J RAHMER | Officer | Jul 29 '24 | Proposed Sale | 8.51 | 12,164 | 103,488 | | Jul 29 04:24 PM | SANJIV PATEL | Officer | Jul 26 '24 | Proposed Sale | 9.07 | 36,706 | 332,769 | | Jul 26 04:47 PM | Bergstrom Donald A | President, R&D | Jun 27 '24 | Sale | 6.26 | 648 | 4,056 | 526,779 | Jul 01 04:42 PM | Rahmer Peter | See remarks | Jun 27 '24 | Sale | 6.26 | 245 | 1,534 | 432,180 | Jul 01 04:41 PM | Catinazzo Thomas | Chief Financial Officer | Jun 27 '24 | Sale | 6.24 | 9,373 | 58,493 | 330,430 | Jul 01 04:41 PM | Adams Brian | Chief Legal Officer | Jun 27 '24 | Sale | 6.26 | 295 | 1,847 | 325,472 | Jul 01 04:38 PM | Rubin Jami | Director | Jun 10 '24 | Option Exercise | 5.04 | 42,242 | 212,900 | 67,242 | Jun 12 04:06 PM | Rahmer Peter | See remarks | Jun 04 '24 | Sale | 6.64 | 40,595 | 269,551 | 452,875 | Jun 05 08:01 PM | Rahmer Peter | See remarks | Jun 05 '24 | Sale | 7.06 | 20,450 | 144,377 | 432,425 | Jun 05 08:01 PM | Rahmer Peter | See remarks | Jun 03 '24 | Sale | 6.47 | 19,864 | 128,520 | 493,470 | Jun 05 08:01 PM | Rahmer Peter | See remarks | Apr 29 '24 | Sale | 6.38 | 1,345 | 8,581 | 513,334 | Apr 29 08:36 PM | Adams Brian | Chief Legal Officer | Apr 29 '24 | Sale | 6.38 | 1,623 | 10,355 | 325,767 | Apr 29 08:33 PM | Catinazzo Thomas | Chief Financial Officer | Apr 29 '24 | Sale | 6.38 | 1,695 | 10,814 | 339,803 | Apr 29 08:31 PM | Bergstrom Donald A | President, R&D | Apr 29 '24 | Sale | 6.38 | 2,686 | 17,137 | 527,427 | Apr 29 08:30 PM | Catinazzo Thomas | Chief Financial Officer | Mar 27 '24 | Sale | 7.70 | 348 | 2,680 | 341,498 | Mar 29 04:15 PM | Bergstrom Donald A | President, R&D | Mar 27 '24 | Sale | 7.70 | 765 | 5,890 | 530,113 | Mar 29 04:15 PM | Rahmer Peter | See remarks | Mar 27 '24 | Sale | 7.70 | 298 | 2,295 | 514,679 | Mar 29 04:15 PM | Adams Brian | Chief Legal Officer | Mar 27 '24 | Sale | 7.70 | 348 | 2,680 | 327,390 | Mar 29 04:15 PM | Rahmer Peter | See remarks | Jan 29 '24 | Sale | 9.64 | 1,651 | 15,916 | 514,977 | Jan 31 04:14 PM | Catinazzo Thomas | Chief Financial Officer | Jan 29 '24 | Sale | 9.64 | 2,005 | 19,328 | 341,846 | Jan 31 04:11 PM | Bergstrom Donald A | President, R&D | Jan 29 '24 | Sale | 9.64 | 3,178 | 30,636 | 530,878 | Jan 31 04:08 PM | Adams Brian | Chief Legal Officer | Jan 29 '24 | Sale | 9.64 | 1,929 | 18,596 | 327,738 | Jan 31 04:05 PM | Rahmer Peter | See remarks | Dec 27 '23 | Sale | 11.51 | 244 | 2,808 | 316,628 | Dec 29 04:26 PM | Catinazzo Thomas | Chief Financial Officer | Dec 27 '23 | Sale | 11.51 | 294 | 3,384 | 143,851 | Dec 29 04:22 PM | Bergstrom Donald A | President, R&D | Dec 27 '23 | Sale | 11.51 | 977 | 11,245 | 234,056 | Dec 29 04:17 PM | Adams Brian | Chief Legal Officer | Dec 27 '23 | Sale | 11.51 | 294 | 3,384 | 129,667 | Dec 29 04:14 PM | Rahmer Peter | See remarks | Oct 30 '23 | Sale | 6.03 | 1,354 | 8,165 | 316,872 | Nov 01 04:21 PM | Catinazzo Thomas | Chief Financial Officer | Oct 30 '23 | Sale | 6.03 | 1,697 | 10,233 | 144,145 | Nov 01 04:18 PM | Bergstrom Donald A | President, R&D | Oct 30 '23 | Sale | 6.03 | 3,451 | 20,810 | 235,033 | Nov 01 04:14 PM | Adams Brian | Chief Legal Officer | Oct 30 '23 | Sale | 6.03 | 1,632 | 9,841 | 129,961 | Nov 01 04:07 PM |
|